Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hartmut Goldschmidt

Showing results (31-40 of 539) with videos related to

Pageof 54
Sort By:
Oncology Letters|January 21, 2017
Diagnostic and therapeutic approaches to multiple myeloma patients: 'Real-world' data from representative multicentre treatment surveys in Germany between 2008 and 2011Thomas M Moehler, Maximilian Merz, Lenka Kellermann, et al.
British Journal of Haematology|November 18, 2003
Dissociation of putative graft-versus-haematopoiesis and graft-versus-myeloma effects in patients with rapidly progressive multiple myelomaThomas Luft, Marion Moos, Hartmut Goldschmidt, et al.
Haematologica|July 1, 2021
Novel immunotherapies in multiple myeloma - chances and challengesLeo Rasche, Ralph Wäsch, Markus Munder, et al.
Cancers|August 27, 2021
Therapeutic Advances Propelled by Deciphering Tumor Biology and Immunology-Highlights of the 8th Heidelberg Myeloma WorkshopRaphael Lutz, Mirco Friedrich, Marc Steffen Raab, et al.
Clinical Nuclear Medicine|November 18, 2022
Unusual Extramedullary Manifestation in Multiple Myeloma: Bilateral Synchronous Testicular InfiltrationDimitrios Strauss, Christos Sachpekidis, Ulrike Dapunt, et al.
Studies in Health Technology and Informatics|August 28, 2014
A reference data model of a metadata registry preserving semantics and representations of data elementsMartin Löpprich, Jennifer Jones, Marie-Claire Meinecke, et al.
Leukemia & Lymphoma|August 20, 2019
Salvage therapy versus upfront autologous stem cell transplantation in multiple myeloma patients with progressive disease after first-line induction therapyJoanna Blocka, Thomas Hielscher, Carsten Mueller-Tidow, et al.
Journal of the American Society of Nephrology : JASN|May 22, 2004
Malignancy in renal transplantationChristian Morath, Martina Mueller, Hartmut Goldschmidt, et al.
Glycobiology|June 12, 2016
Galectin-8 enhances adhesion of multiple myeloma cells to vascular endothelium and is an adverse prognostic factorMyriam Friedel, Sabine André, Hartmut Goldschmidt, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 31, 2013
Classical hodgkin lymphoma as de novo B-cell malignancy after treatment of multiple myeloma in the pre-lenalidomide eraManola Zago, Patrick Adam, Hartmut Goldschmidt, et al.
Pageof 54

Showing results (31-40 of 539) with videos related to

Sort By:
Pageof 54
Oncology Letters|January 21, 2017
Diagnostic and therapeutic approaches to multiple myeloma patients: 'Real-world' data from representative multicentre treatment surveys in Germany between 2008 and 2011Thomas M Moehler, Maximilian Merz, Lenka Kellermann, et al.
British Journal of Haematology|November 18, 2003
Dissociation of putative graft-versus-haematopoiesis and graft-versus-myeloma effects in patients with rapidly progressive multiple myelomaThomas Luft, Marion Moos, Hartmut Goldschmidt, et al.
Haematologica|July 1, 2021
Novel immunotherapies in multiple myeloma - chances and challengesLeo Rasche, Ralph Wäsch, Markus Munder, et al.
Cancers|August 27, 2021
Therapeutic Advances Propelled by Deciphering Tumor Biology and Immunology-Highlights of the 8th Heidelberg Myeloma WorkshopRaphael Lutz, Mirco Friedrich, Marc Steffen Raab, et al.
Clinical Nuclear Medicine|November 18, 2022
Unusual Extramedullary Manifestation in Multiple Myeloma: Bilateral Synchronous Testicular InfiltrationDimitrios Strauss, Christos Sachpekidis, Ulrike Dapunt, et al.
Studies in Health Technology and Informatics|August 28, 2014
A reference data model of a metadata registry preserving semantics and representations of data elementsMartin Löpprich, Jennifer Jones, Marie-Claire Meinecke, et al.
Leukemia & Lymphoma|August 20, 2019
Salvage therapy versus upfront autologous stem cell transplantation in multiple myeloma patients with progressive disease after first-line induction therapyJoanna Blocka, Thomas Hielscher, Carsten Mueller-Tidow, et al.
Journal of the American Society of Nephrology : JASN|May 22, 2004
Malignancy in renal transplantationChristian Morath, Martina Mueller, Hartmut Goldschmidt, et al.
Glycobiology|June 12, 2016
Galectin-8 enhances adhesion of multiple myeloma cells to vascular endothelium and is an adverse prognostic factorMyriam Friedel, Sabine André, Hartmut Goldschmidt, et al.
Clinical Lymphoma, Myeloma & Leukemia|October 31, 2013
Classical hodgkin lymphoma as de novo B-cell malignancy after treatment of multiple myeloma in the pre-lenalidomide eraManola Zago, Patrick Adam, Hartmut Goldschmidt, et al.
Pageof 54